Autonomix Medical Inc.
Autonomix Medical Inc. (AMIX): 1 pipeline candidate. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
N/A
D/E 0.29 · 0% dilution
Lead: Preclinical
1 candidate
N/A
N/A
A transparent, data-derived signal for Autonomix Medical Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$4.5M
Cash
$7.0M
Quarterly Burn
—
Runway
—
Revenue
—
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| autonomix system | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
8
Total value held
$79K
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 175,621 | $69K |
| bank of montreal /can/ | 25,000 | $10K |
| pnc financial services group, inc. | 1,588 | $619 |
| farther finance advisors, llc | 10 | $4 |
| harbour investments, inc. | 10 | $4 |
| key capital management, inc | 10 | $4 |
| swan capital llc | 10 | $4 |
| national bank of canada /fi/ | 7 | $3 |
Frequently asked questions
How many drug candidates are in Autonomix Medical Inc.'s pipeline?
Autonomix Medical Inc. (AMIX) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is Autonomix Medical Inc.'s lead drug candidate?
Autonomix Medical Inc.'s most advanced tracked candidate is autonomix system (Preclinical) for Pain associated with pancreatic cancer.
What is Autonomix Medical Inc.'s market capitalization?
Autonomix Medical Inc.'s market capitalization is approximately $4.5M.
Who is the CEO of Autonomix Medical Inc.?
Mr. Bradley Hauser is the chief executive officer of Autonomix Medical Inc. (AMIX).
Get the full picture on Autonomix Medical Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.